Literature DB >> 20047469

Global repression of cancer gene expression in a zebrafish model of melanoma is linked to epigenetic regulation.

Viviana Anelli1, Cristina Santoriello, Martin Distel, Reinhard W Köster, Francesca D Ciccarelli, Marina Mione.   

Abstract

We have established a model of melanoma progression in zebrafish through the generation of transgenic lines specifically expressing oncogenic human HRAS in the melanocytic lineage. In these tumors we have carried out quantitative expression analysis of several putative cancer genes, from known and predicted cancer gene lists. In particular, we analyzed 39 out of 101 putative cancer genes identified with a bioinformatics approach and selected for the low frequency of duplication and the high connectivity in protein networks. Data obtained by real-time polymerase chain reaction analysis from zebrafish melanoma tissue shows that the expression of many cancer genes is downregulated in zebrafish melanomas, whereas only cell cycle genes are upregulated. To understand whether this trend is due to global repression of gene expression associated to a repressive chromatin state, we investigated whether changes of histone methylation were detectable in our melanoma model. We found substantial differences in the levels of H3K9me3, H4K20me2, H3K27me3, H3K4me3, and H3R2me2a immunostaining in melanoma tissue when compared with normal skin. Thus our analysis suggests that in our model, like in human melanoma, important changes occur to the methylation status of histones. Although the outcome of these changes is still unknown, they could be responsible for the global repression of gene expression through epigenetic regulation shown in this study.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20047469     DOI: 10.1089/zeb.2009.0612

Source DB:  PubMed          Journal:  Zebrafish        ISSN: 1545-8547            Impact factor:   1.985


  19 in total

1.  The zebrafish as a model for cancer.

Authors:  Marina C Mione; Nikolaus S Trede
Journal:  Dis Model Mech       Date:  2010-03-30       Impact factor: 5.758

Review 2.  Epigenetics, development, and cancer: zebrafish make their mark..

Authors:  Raksha Mudbhary; Kirsten C Sadler
Journal:  Birth Defects Res C Embryo Today       Date:  2011-06

Review 3.  Zebrafish Discoveries in Cancer Epigenetics.

Authors:  Yelena Chernyavskaya; Brandon Kent; Kirsten C Sadler
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 4.  Genetic and environmental melanoma models in fish.

Authors:  E Elizabeth Patton; David L Mitchell; Rodney S Nairn
Journal:  Pigment Cell Melanoma Res       Date:  2010-03-08       Impact factor: 4.693

5.  The Zebrafish as a Tool to Cancer Drug Discovery.

Authors:  L N Huiting; Fjf Laroche; H Feng
Journal:  Austin J Pharmacol Ther       Date:  2015-05-04

6.  Conserved expression signatures between medaka and human pigment cell tumors.

Authors:  Manfred Schartl; Susanne Kneitz; Brigitta Wilde; Toni Wagner; Christiaan V Henkel; Herman P Spaink; Svenja Meierjohann
Journal:  PLoS One       Date:  2012-05-31       Impact factor: 3.240

7.  Kita driven expression of oncogenic HRAS leads to early onset and highly penetrant melanoma in zebrafish.

Authors:  Cristina Santoriello; Elisa Gennaro; Viviana Anelli; Martin Distel; Amanda Kelly; Reinhard W Köster; Adam Hurlstone; Marina Mione
Journal:  PLoS One       Date:  2010-12-10       Impact factor: 3.240

8.  Live imaging of innate immune cell sensing of transformed cells in zebrafish larvae: parallels between tumor initiation and wound inflammation.

Authors:  Yi Feng; Cristina Santoriello; Marina Mione; Adam Hurlstone; Paul Martin
Journal:  PLoS Biol       Date:  2010-12-14       Impact factor: 8.029

Review 9.  From fish bowl to bedside: The power of zebrafish to unravel melanoma pathogenesis and discover new therapeutics.

Authors:  Ellen van Rooijen; Maurizio Fazio; Leonard I Zon
Journal:  Pigment Cell Melanoma Res       Date:  2017-06-08       Impact factor: 4.693

Review 10.  Small molecule screening in zebrafish: swimming in potential drug therapies.

Authors:  Owen J Tamplin; Richard M White; Lili Jing; Charles K Kaufman; Scott A Lacadie; Pulin Li; Alison M Taylor; Leonard I Zon
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012-02-28       Impact factor: 5.814

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.